These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders. Swinnen LJ Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187 [TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal post-transplant lymphoproliferative disorder with rapidly forming characteristic lesions after cord blood transplantation: a report of two cases]. Sato Y; Sumi M; Ueki T; Kaiume H; Kirihara T; Takeda W; Kurihara T; Sato K; Hiroshima Y; Tokutake K; Kimura T; Watanabe M; Kobayashi H Rinsho Ketsueki; 2016; 57(12):2496-2501. PubMed ID: 28090016 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case. Shitrit D; Shitrit AB; Dickman R; Sahar G; Saute M; Kramer MR Dis Colon Rectum; 2005 Nov; 48(11):2144-7. PubMed ID: 16086224 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus associated post-transplantation lymphoproliferative disorder with hemophagocytosis in a child with Wiskott-Aldrich syndrome. Wang IJ; Lu MY; Chiang BL; Lin WC; Lin DT; Lin KH Pediatr Blood Cancer; 2005 Sep; 45(3):340-3. PubMed ID: 15547918 [TBL] [Abstract][Full Text] [Related]
11. Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia. Rudzki Z; Werda L; Piatkowska-Jakubas B; Mensah P; Zazula M; Białas M; Skotnicki AB; Stachura J Pol J Pathol; 2002; 53(1):35-40. PubMed ID: 12014224 [TBL] [Abstract][Full Text] [Related]
13. Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation. Cornejo A; Bohnenblust M; Harris C; Abrahamian GA Cancer Chemother Pharmacol; 2009 Sep; 64(4):857-60. PubMed ID: 19588139 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab. Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811 [TBL] [Abstract][Full Text] [Related]
15. Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients. Görzer I; Puchhammer-Stöckl E; van Esser JW; Niesters HG; Cornelissen JJ Clin Infect Dis; 2007 Mar; 44(5):693-5. PubMed ID: 17278061 [TBL] [Abstract][Full Text] [Related]